- NCT00211120
- Primary Citation
- Data Specification Not Available
Trial Information
Generic NameEpoetin alfaProduct NamePROCRIT®Therapeutic AreaBlood and Lymph ConditionsEnrollment1432% Female55.2%% White61.7%
Product ClassHematologic AgentsSponsor Protocol NumberPR00-06-014Data PartnerJohnson & JohnsonCondition StudiedAnemiaMean/Median Age (Years)66.2
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available